February 2019
Volume 14 Issue 2 |
|
|
|
|
Features
Drug solubility can benefit from approaching solubility issues early on in the drug lifecycle.
/ read more /
Ensuring the stability of biotherapeutics can be achieved through kinetic models that study aggregation and fragmentation.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
News
The company will invest $4 million to increase topical and transdermal formulation development and performance testing services at its Durham, NC, facility.
/ read more /
Horizon and Rutgers University will partner to develop and commercialize new gene editing technology for therapeutic and research applications.
/ read more /
|
|
|
|
|
The Dublin, Ireland-based biopharmaceutical company will establish an R&D presence in Cambridge, MA.
/ read more /
The companies will embark on a multi-year research collaboration to develop in-vivo delivery modalities for CRISPR/Cas9 by leveraging ProBioGen's existing technology and expertise.
/ read more /
Solentim and ATUM have announced a technology collaboration agreement that will focus on the creation of an efficient cell-line development solution for biotherapeutic drug developers.
/ read more /
Taconic Biosciences, a provider of genetically engineered rodent model solutions, sent mice into space to advance research on new therapies for aging-related disease processes.
/ read more /
|
|
|
New Technology
Formulatrix's FLO i8 and Flow Axial Seal Tip liquid handlers offer automated transferring.
/ read more /
The company has built a fit-for-purpose liquid chromatography–mass spectrometry (LC–MS) system to streamline analytical monitoring tests for biopharmaceuticals.
/ read more /
A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.
/ read more /
|
|
|
|
|
